Vivimed Labs Ltd

₹ 4.95 -1.00%

31 Jul 2023

vivimedlabs.com BSE: 532660 NSE: VIVIMEDLAB

About

Vivimed Labs Ltd is primarily engaged in the business of APIs, CDMO, Finished Dosage Formulation, Specialty Chemicals and retail branded formulation manufacturing.^[1]

Key Points

API Division (~69% of revenues)^[1]
This is the flagship division of the company which is primarily managed by its subsidiary UQUIFA s.a. based in Spain. The division further has 2 sub-divisions :-^[2]

Website BSE NSE - BZ

Market Cap ₹ 41.0 Cr.
Current Price ₹ 4.95
High / Low ₹ /
Stock P/E
Book Value ₹ -5.79
Dividend Yield 0.00 %
ROCE -8.10 %
ROE %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -35.7% over past five years.
Promoter holding is low: 7.77%
Contingent liabilities of Rs.183 Cr.
Earnings include an other income of Rs.4.88 Cr.
Company has high debtors of 233 days.
Promoter holding has decreased over last 3 years: -13.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	44.22	55.74	37.03	35.35	33.64	41.46	38.62	29.37	24.77	36.51	25.61	21.39	20.61
	53.53	60.87	201.32	35.68	39.54	40.19	67.09	40.37	25.41	35.46	28.08	21.67	21.56
Operating Profit	-9.31	-5.13	-164.29	-0.33	-5.90	1.27	-28.47	-11.00	-0.64	1.05	-2.47	-0.28	-0.95
OPM %	-21.05%	-9.20%	-443.67%	-0.93%	-17.54%	3.06%	-73.72%	-37.45%	-2.58%	2.88%	-9.64%	-1.31%	-4.61%
	0.15	0.05	0.68	0.11	2.20	0.04	7.63	0.06	0.03	0.07	4.22	0.38	0.21
Interest	8.85	9.22	8.52	10.66	11.89	13.21	-33.33	0.30	0.43	0.48	1.74	0.58	1.66
Depreciation	4.02	4.02	95.92	4.70	4.70	4.70	5.84	4.01	4.10	6.62	5.50	5.01	4.90
Profit before tax	-22.03	-18.32	-268.05	-15.58	-20.29	-16.60	6.65	-15.25	-5.14	-5.98	-5.49	-5.49	-7.30
Tax %	0.00%	0.00%	-0.77%	0.00%	0.00%	-3.31%	20.90%	0.00%	0.00%	0.00%	2.19%	0.00%	0.00%
	-22.03	-18.31	-265.99	-15.58	-20.30	-16.05	5.26	-15.25	-5.14	-5.98	-5.60	-5.49	-7.30
EPS in Rs	-2.66	-2.21	-32.08	-1.88	-2.45	-1.94	0.63	-1.84	-0.62	-0.72	-0.68	-0.66	-0.88
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	1,351	1,380	1,346	1,462	1,186	1,315	1,059	861	237	187	149	116	104
	1,139	1,156	1,111	1,057	971	1,135	1,049	830	245	374	182	129	107
Operating Profit	212	224	234	404	215	180	10	32	-8	-187	-33	-13	-3
OPM %	16%	16%	17%	28%	18%	14%	1%	4%	-3%	-100%	-22%	-11%	-3%
	8	6	11	8	10	23	8	10	1	1	10	4	5
Interest	67	86	84	68	82	70	61	56	40	36	3	3	4
Depreciation	66	66	61	58	56	67	67	56	18	108	20	20	22
Profit before tax	87	78	100	286	86	66	-109	-70	-65	-331	-46	-32	-24
Tax %	24%	7%	16%	25%	11%	13%	-0%	3%	4%	-1%	-1%	0%
	66	72	84	214	76	57	-109	-72	-68	-329	-45	-32	-24
EPS in Rs	8.20	8.90	10.33	26.41	9.44	6.95	-13.16	-8.67	-8.16	-39.62	-5.48	-3.85	-2.94
Dividend Payout %	7%	0%	0%	2%	4%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	-22%
5 Years:	-36%
3 Years:	-21%
TTM:	-22%

Compounded Profit Growth
10 Years:	%
5 Years:	11%
3 Years:	15%
TTM:	22%

Stock Price CAGR
10 Years:	-25%
5 Years:	-22%
3 Years:	-27%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	16	16	16	16	17	17	17	17	17	17	17	17	17
Reserves	480	479	505	718	885	602	493	415	348	23	-22	-52	-65
	958	1,076	1,015	1,011	1,149	1,280	1,268	326	359	379	377	376	384
	404	327	519	317	343	431	432	532	543	658	579	580	588
Total Liabilities	1,858	1,898	2,055	2,062	2,394	2,329	2,210	1,289	1,266	1,076	950	921	924
	808	813	814	879	1,035	965	1,045	502	520	436	418	408	393
CWIP	38	90	94	76	65	122	89	60	40	21	21	17	21
Investments	0	3	3	3	3	3	86	199	199	199	168	168	168
	1,011	992	1,144	1,104	1,290	1,239	990	529	507	421	343	328	342
Total Assets	1,858	1,898	2,055	2,062	2,394	2,329	2,210	1,289	1,266	1,076	950	921	924

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-118	140	154	58	21	422	80	567	28	35	-24	-2
	-291	-107	-190	-68	-164	-89	-196	404	-16	-5	28	-5
	419	-42	41	35	186	-338	72	-1,015	-10	-34	-6	5
Net Cash Flow	11	-8	4	25	44	-5	-44	-44	1	-3	-2	-1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	94	87	88	50	85	99	86	46	134	145	203	233
Inventory Days	249	244	294	329	411	397	396	263	573	216	327	358
Days Payable	106	107	98	122	154	207	179	35	100	74	225	240
Cash Conversion Cycle	237	224	285	258	342	288	303	274	607	286	305	351
Working Capital Days	57	43	58	55	121	68	216	77	195	-15	-171	-255
ROCE %	12%	11%	12%	22%	9%	7%	-3%	-1%	-3%	-52%	-11%	-8%

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	20.96%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	7.76%	7.76%
	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%
	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%
	77.29%	77.30%	77.30%	77.29%	77.30%	77.29%	77.30%	77.30%	77.30%	77.30%	90.47%	90.47%
No. of Shareholders	51,026	50,683	49,503	49,038	49,027	49,016	49,012	49,003	49,005	48,957	48,928	48,925

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
	36.48%	36.64%	34.39%	32.79%	28.57%	21.98%	20.94%	20.94%	20.94%	7.76%
	4.23%	5.24%	4.07%	3.56%	3.10%	1.64%	1.64%	1.64%	1.64%	1.64%
	0.33%	0.30%	0.48%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%
	58.85%	57.71%	60.94%	63.53%	68.21%	76.27%	77.30%	77.29%	77.30%	90.47%
No. of Shareholders	19,274	30,575	33,380	30,638	37,989	53,110	50,683	49,016	48,957	48,925

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

Aug 2019

Transcript

AI Summary
PPT
Mar 2019

Transcript

AI Summary
PPT
Nov 2018

Transcript

AI Summary
PPT
Aug 2018

Transcript

AI Summary
PPT
Jun 2018

Transcript

AI Summary
PPT
Feb 2018

Transcript

AI Summary
PPT
Nov 2017

Transcript

AI Summary
PPT
Aug 2017
Transcript PPT
Nov 2016
Transcript PPT
Aug 2016
Transcript PPT
May 2016
Transcript PPT
Aug 2015

Transcript

AI Summary
PPT